Hydralazine HCl rapidly disintegrating sublingual tablets: simple dosage form of higher bioavailability and enhanced clinical efficacy for potential rapid control on hypertensive preeclampsia

References

• ReyELelorierJBurgessELangeIRLeducLReport of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancyCMAJ19971579124512549361646
   PubMed Web of Science ®Google Scholar
• WeberMASchiffrinELWhiteWBClinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of HypertensionJ Clin Hypertens2014321315
   Google Scholar
• JamesPAOparilSCarterBLEvidence-based guideline for the management of high blood pressure in adultsJAMA2014311550752024352797
   PubMed Web of Science ®Google Scholar
• EckelRHJakicicJMArdJDAHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesCirculation20132014129S76S99
   Google Scholar
• LewisGDrifeJDieWMThe Fifth Report of the Confidential Enquiries intoMaternal Deaths in the United Kingdom2001LondonRCOG Press19971999
   Google Scholar
• CooperGMLewisGNeilsonJConfidential enquiries into maternal deaths, 1997–1999Br J Anaesth200289336937212402712
   PubMed Web of Science ®Google Scholar
• RoccellaEJReport of the National High Blood Pressure Education Program Working Group on High Blood Pressure in PregnancyAm J Obstet Gynecol2000183112210920299
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and GynecologistsTask force on hypertension in pregnancyHypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in PregnancyObstet Gynecol2013122112251131
   Google Scholar
• MageeLAPelsAHelewaMCanadian Hypertensive Disorders of Pregnancy Working Group. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summaryJ Obstet Gynaecol Can201436541644124927294
   PubMedGoogle Scholar
• ThongBYTanTCEpidemiology and risk factors for drug allergyBr J Clin Pharmacol201171568470021480948
   PubMed Web of Science ®Google Scholar
• BhanjaSBEllaiahPRoyHKFormulation and evaluation of per-indopril sublingual tabletsInt J Res Pharm Biomed Sc20112311931198
   Google Scholar
• SahaPVermaSDasPSSublingual drug delivery: an indication of potential alternative routeInt J Curr Pharm Res20179657
   Google Scholar
• BirudarajRBernerBShenSLiXBuccal permeation of buspirone: mechanistic studies on transport pathwaysJ Pharm Sci2005941707815761931
   PubMed Web of Science ®Google Scholar
• BindAKGnanarajanGKothiyalPA review: sublingual route for systemic drug deliveryInt J Drug Res Tech2013323136
   Google Scholar
• Hetero drugs limited, Hydralazine hydrochloride tablets, USP2008 Available from: https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=a2b73026-2451-406f-b866-9dc16177cb44&type=display [online]AccessedNovember 8, 2017
   Google Scholar
• SinghBPahujaSKapilRAhujaNFormulation development of oral controlled release tablets of hydralazine: optimization of drug release and bioadhesive characteristicsActa Pharm200959111319304554
   PubMed Web of Science ®Google Scholar
• OatesJABrownNJAntihypertensive Agents and the Drug Therapy of Hypertension, in Goodman & Gilman’s The Pharmacological Basis of Therapeutics10th edHardmanJGLimbirdLENew YorkMc Graw Hill Medical Publishing Division2001871900
   Google Scholar
• KhamesALiquisolid technique: a promising alternative to conventional coating for improvement of drug photostability in solid dosage formsExpert Opin Drug Deliv201310101335134323706099
   PubMed Web of Science ®Google Scholar
• PharmacopeiaUSFormularyNU.S. Pharmacopeia and National Formulary. USP 25-NF 20 Supplement 1: United States Pharmacopeial Convention, Incorporated2002
   Google Scholar
• KaurRSharmaGNagpalMpreparation and characterization of fast disintegrating tablets of hydralazine hydrochloride using design of experiment techniqueJ Biomed Pharm Res20143116
   Google Scholar
• PrajapatiSTPatelPBPatelCNFormulation and evaluation of sub-lingual tablets containing Sumatriptan succinateInt J Pharm Investig201223162168
   PubMedGoogle Scholar
• BhanjaSBEllaiahPRoyHKFormulation and evaluation of perindopril sublingual tabletsInt J Res Pharm Biomed Sci20112311301198
   Google Scholar
• KhamesAInvestigation of the effect of solubility increase at the main absorption site on bioavailability of BCS class II drug (risperidone) using liquisolid techniqueDrug Deliv201724132833828165818
   PubMed Web of Science ®Google Scholar
• AburahmaMHEl-LaithyHMHamzaY-SHananMPreparation and in vitro/in vivo characterization of porous sublingual tablets containing ternary kneaded solid system of vinpocetine with î-cyclodextrin and hydroxy acidSci Pharm201078236337921179352
   PubMedGoogle Scholar
• MañesJMariJGarciaRFontGLiquid chromatographic determination of hydralazine in human plasma with 2-hydroxy-1-naph-thaldehyde pre-column derivatizationJ Pharm Biomed Anal199088–127957982100625
   PubMed Web of Science ®Google Scholar
• MottaCGrossoCZanuzziCEffect of sildenafil on pre-eclampsia-like mouse model induced by L-NAMEReprod Domest Anim201550461161625959785
   PubMed Web of Science ®Google Scholar
• McCarthyFPKingdomJCKennyLCWalshSKAnimal models of preeclampsia; uses and limitationsPlacenta201132641341921497901
   PubMed Web of Science ®Google Scholar
• PodjarnyEBen-ChetritSRathausMPregnancy-induced hypertension in rats with adriamycin nephropathy is associated with an inadequate production of nitric oxideHypertension19972949869919095088
   PubMed Web of Science ®Google Scholar
• VanithaKVarmaMRameshAMohan VarmaARFloating tablets of hydralazine hydrochloride: optimization and evaluationBrazilian J Pharm Sci2013494811819
   Web of Science ®Google Scholar
• RekhiGHammSSidwellRControlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochlorideUnited States patent US93081772016 Google Patents
   Google Scholar
• OoiTChemistry. Heat and light switch a chiral catalyst and its productsScience201133160231395139621415343
   PubMed Web of Science ®Google Scholar
• Swamy KumaraSNagarjun ReddyLAgaiah GoudBDevelopment and in vitro evaluation of bioadhesive buccal tablets of hydralazine hydrochlorideInt J Pharm Educ Res201412816
   Google Scholar
• MorinGBriensLThe effect of lubricants on powder flowability for pharmaceutical applicationAAPS Pharm Sci Tech201314311581168
   PubMed Web of Science ®Google Scholar
• SarraguçaMCCruzAVSoaresSOAmaralHRCostaPCLopesJADetermination of flow properties of pharmaceutical powders by near infrared spectroscopyJ Pharm Biomed Anal201052448449220167448
   PubMed Web of Science ®Google Scholar
• OdouPBarthélémyCChatelierDPharmacokinetics of midazolam: comparison of sublingual and intravenous routes in rabbitEur J Drug Metab Pharmacokinet19992411710412885
   PubMed Web of Science ®Google Scholar
• Proposal to waive in vivo bioequivalence requirements for the WHO model list of essential medicines immediate release, solid oral dosage formsWHO2005 Available from: http://www.who.int/medicines/services/expertcommittees/pharmprep/QAS04_109Rev1_Waive_invivo_bioequiv.pdf [online]Accessed December 15, 2017
   Google Scholar
• LeaLSublingual absorption1996 Available from: http://www.positivehealth.com/article/colonhealth/sublingual-absorption [online]AccessedDecember 18, 2017
   Google Scholar
• MakinoIShibataKMakinoYKangawaKKawarabayashiTAdrenomedullin attenuates the hypertension in hypertensive pregnant rats induced by N(G)-nitro-l-arginine methyl esterEur J Pharmacol19993712–315916710357253
   PubMed Web of Science ®Google Scholar
• RathboneMichael J.DrummondBernadette K.TuckerIan G.The oral cavity as a site for systemic drug deliveryAdv Drug Deliver Rev1994131–2122
   Web of Science ®Google Scholar
• BartlettJAvan der Voort MaarschalkKMaarschalk KvandervUnderstanding the oral mucosal absorption and resulting clinical pharmacokinetics of asenapineAAPS Pharm Sci Tech201213411101115
   PubMed Web of Science ®Google Scholar
• NarangNSharmaJSublingual mucosa as a route for systemic drug deliveryInt J Pharm Sci20113126573
   Google Scholar